- School of Public Policy
Aaron D. Levine is an Associate Professor in the School of Public Policy at Georgia Tech and a Guest Researcher in the Division of Reproductive Health at the Centers for Disease Control and Prevention. His research focuses on the intersection between public policy and bioethics. Much of his recent work has examined the development of stem cell science, particularly research using human embryonic stem cells, and the oversight of contentious areas of medicine, such as assisted reproductive technology. In 2012, he received a five-year NSF CAREER award to examine the impact of ethical controversy on graduate science education and the development of scientific careers. Aaron is Co-Director for Engineering Workforce Development for the NSF Engineering Research Center for Cell Manufacturing Technologies (CMaT). He is also the author of Cloning: A Beginner’s Guide (Oneworld Publications, 2007), an accessible introduction to the science of cloning and embryonic stem cells and the ethical and policy controversies this science inspires.
Aaron completed his Ph.D. in Public Affairs at Princeton University, where his dissertation research examined the impact of public policy on the development of human embryonic stem cell science. He also holds an M. Phil. from the University of Cambridge, where, as a Churchill Scholar, he studied computational biology at the Sanger Centre and developed algorithms to help analyze the human genome sequence, and a B.S. in Biology from the University of North Carolina at Chapel Hill, where he was a Morehead Scholar
- Ph.D., Princeton University, Public Affairs
- M.Phil., University of Cambridge, Biological Sciences
- B.S., University of North Carolina at Chapel Hill, Biology
- Ethics and Philosophy of Science and Technology
- S&E Organizations, Education, Careers and Workforce
- Science, Technology, and Innovation Policy
- PHIL-3127: Sci, Tech & Human Values
- POL-1101: Government of the U.S.
- PST-3127: Sci,Tech & Human Values
- PUBJ-8000: Joint GT/GSU PhD Program
- PUBP-3030: Policy Analysis
- PUBP-3130: Research Methods
- PUBP-3244: Stem Cell Policy Ethics
- PUBP-6112: Research Dsgn-Polcy Sci
- PUBP-8813: Special Topics
- Contribution of Assisted Reproductive Technology to Overall Births by Maternal Age in the United States, 2012-2014
In: Journal of the American Medical Association [Peer Reviewed]
- Assessing state stem cell programs in the United States: How has state funding affected publication trends?
In: Cell Stem Cell [Peer Reviewed]
© 2015 Elsevier Inc. All rights reserved.Several states responded to federal funding limitations placed on human embryonic stem cell research and the potential of the field by creating state stem cell funding programs, yet little is known about the impact of these programs. Here we examine how state programs have affected publication trends in four states.
- Challenges in the commercialization and translation of cell therapies
In: BMC Biotechnology [Peer Reviewed]
- Self-regulation, compensation, and the ethical recruitment of oocyte donors.
In: Hastings Cent Rep [Peer Reviewed]
Over the last couple of decades, oocyte donation has become common, important, and sometimes lucrative. Women who donate eggs are often offered fees, though ostensibly only to offset their expenses and limited to no more than $10,000, following recommendations adopted by the fertility industry. Is the industry adhering to its recommendations? A study of advertisements published in college newspapers raises questions.
- Ethical Considerations in the Translation of CAR-T Cell Therapies
In: Cell & Gene Therapy Insights [Peer Reviewed]
- State differences in pluripotent and adult stem cell research, 2009-2016
In: Regenerative Medicine [Peer Reviewed]
- Medical societies, patient education initiatives, public debate and marketing of unproven stem cell interventions
In: Cytotherapy [Peer Reviewed]
- Assessing the use of assisted reproductive technology in the United States by non-United States residents
In: Fertility and Sterility [Peer Reviewed]
- Differences in the utilization of gestational surrogacy between states in the USA
In: Reproductive BioMedicine & Society [Peer Reviewed]